293 participants
An Extension Study to Determine the Safety and Anti-Leukemic Effects of Imatinib Mesylate in Adult Participants With Ph+ Leukemia
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-07-22
- Start Date:
- 1999-08-09
- Completion:
- 2013-09-23
Conditions
- Philadelphia Positive Chronic Myeloid Leukemia
- Acute Lymphoblastic Leukemia
- Acute Myeloid Leukemia
Interventions
- DRUG